TY - JOUR
T1 - Synthesis, in vitro evaluation of thymidine phosphorylase inhibitory activity, and in silico study of 1,3,5-triazin-2,4-dione and its fused analogues
AU - Bera, Hriday
AU - Chui, Wai-Keung
AU - Gupta, Sayan Dutta
AU - Dolzhenko, Anton V
AU - Sun, Lingyi
PY - 2013
Y1 - 2013
N2 - Based on structural similarities with the reference compounds, a series of 1,3,5-triazin-2,4-dione and their fused analogues was designed, synthesized and their in vitro thymidine phosphorylase inhibitory potential was evaluated. The monocyclic analogues were found to be inactive. Among the different fused derivatives synthesized, compounds having keto group (C=O) at C7/C4 and thioketo group (C=S) at C5/C2 position showed TP inhibitory activity comparable to positive control, 7-deazaxanthine (7-DX) (IC50 value = 42.63 ?M). Molecular docking of the target compounds into the enzyme thymidine phosphorylase was performed to illustrate the important structural information on the plausible ligand-enzyme-binding interactions.
AB - Based on structural similarities with the reference compounds, a series of 1,3,5-triazin-2,4-dione and their fused analogues was designed, synthesized and their in vitro thymidine phosphorylase inhibitory potential was evaluated. The monocyclic analogues were found to be inactive. Among the different fused derivatives synthesized, compounds having keto group (C=O) at C7/C4 and thioketo group (C=S) at C5/C2 position showed TP inhibitory activity comparable to positive control, 7-deazaxanthine (7-DX) (IC50 value = 42.63 ?M). Molecular docking of the target compounds into the enzyme thymidine phosphorylase was performed to illustrate the important structural information on the plausible ligand-enzyme-binding interactions.
UR - http://www.ingentaconnect.com/content/klu/44/2013/00000022/00000012/00000589
U2 - 10.1007/s00044-013-0589-1
DO - 10.1007/s00044-013-0589-1
M3 - Article
SN - 1054-2523
VL - 22
SP - 6010
EP - 6021
JO - Medicinal Chemistry Research
JF - Medicinal Chemistry Research
IS - 12
ER -